Author Correction: PGBD5 promotes site-specific oncogenic mutations in human tumors

Anton G Henssen^#^{1

2}, Richard Koche^#³, Jiali Zhuang^#⁴, Eileen Jiang¹, Casie Reed¹, Amy Eisenberg¹, Eric Still¹, Ian C MacArthur¹, Elias Rodríguez-Fos⁵, Santiago Gonzalez⁵, Montserrat Puiggròs⁵, Andrew N Blackford⁶, Christopher E Mason⁷, Elisa de Stanchina⁸, Mithat Gönen⁹, Anne-Katrin Emde¹⁰, Minita Shah¹⁰, Kanika Arora¹⁰, Catherine Reeves¹⁰, Nicholas D Socci¹¹, Elizabeth Perlman¹², Cristina R Antonescu¹³, Charles W M Roberts¹⁴, Hanno Steen¹⁵, Elizabeth Mullen¹⁶, Stephen P Jackson^{6

17

18}, David Torrents^{5

19}, Zhiping Weng⁴, Scott A Armstrong^{3

20

21}, Alex Kentsis^{22

23

24}

Affiliations

¹ Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
² Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
³ Cancer Biology & Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
⁴ Program in Bioinformatics and Integrative Biology, Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA, USA.
⁵ Joint BSC-CRG-IRB Research Program in Computational Biology, Barcelona Supercomputing Center (BSC-CNS), Barcelona, Spain.
⁶ The Wellcome Trust/Cancer Research UK Gurdon Institute, University of Cambridge, Cambridge, UK.
⁷ Institute for Computational Biomedicine, Weill Cornell Medical College, New York, NY, USA.
⁸ Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
⁹ Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
¹⁰ New York Genome Center, New York, NY, USA.
¹¹ Bioinformatics Core, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
¹² Northwestern University Feinberg School of Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.
¹³ Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
¹⁴ Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA.
¹⁵ Department of Pathology, Boston Children's Hospital, Boston, MA, USA.
¹⁶ Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
¹⁷ Department of Biochemistry, University of Cambridge, Cambridge, UK.
¹⁸ The Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK.
¹⁹ Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.
²⁰ Weill Cornell Medical College, Cornell University, New York, NY, USA.
²¹ Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
²² Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA. kentsisresearchgroup@gmail.com.
²³ Weill Cornell Medical College, Cornell University, New York, NY, USA. kentsisresearchgroup@gmail.com.
²⁴ Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. kentsisresearchgroup@gmail.com.

^# Contributed equally.

PMID: 32918070
DOI: 10.1038/s41588-020-00711-z

Published Erratum

Author Correction: PGBD5 promotes site-specific oncogenic mutations in human tumors

Anton G Henssen et al. Nat Genet. 2020 Nov.

. 2020 Nov;52(11):1265.

doi: 10.1038/s41588-020-00711-z.

Authors

Affiliations

¹ Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
² Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
³ Cancer Biology & Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
⁴ Program in Bioinformatics and Integrative Biology, Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA, USA.
⁵ Joint BSC-CRG-IRB Research Program in Computational Biology, Barcelona Supercomputing Center (BSC-CNS), Barcelona, Spain.
⁶ The Wellcome Trust/Cancer Research UK Gurdon Institute, University of Cambridge, Cambridge, UK.
⁷ Institute for Computational Biomedicine, Weill Cornell Medical College, New York, NY, USA.
⁸ Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
⁹ Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
¹⁰ New York Genome Center, New York, NY, USA.
¹¹ Bioinformatics Core, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
¹² Northwestern University Feinberg School of Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.
¹³ Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
¹⁴ Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA.
¹⁵ Department of Pathology, Boston Children's Hospital, Boston, MA, USA.
¹⁶ Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
¹⁷ Department of Biochemistry, University of Cambridge, Cambridge, UK.
¹⁸ The Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK.
¹⁹ Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.
²⁰ Weill Cornell Medical College, Cornell University, New York, NY, USA.
²¹ Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
²² Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA. kentsisresearchgroup@gmail.com.
²³ Weill Cornell Medical College, Cornell University, New York, NY, USA. kentsisresearchgroup@gmail.com.
²⁴ Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. kentsisresearchgroup@gmail.com.

^# Contributed equally.

PMID: 32918070
DOI: 10.1038/s41588-020-00711-z

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

PubMed Disclaimer

Erratum for

PGBD5 promotes site-specific oncogenic mutations in human tumors.
Henssen AG, Koche R, Zhuang J, Jiang E, Reed C, Eisenberg A, Still E, MacArthur IC, Rodríguez-Fos E, Gonzalez S, Puiggròs M, Blackford AN, Mason CE, de Stanchina E, Gönen M, Emde AK, Shah M, Arora K, Reeves C, Socci ND, Perlman E, Antonescu CR, Roberts CWM, Steen H, Mullen E, Jackson SP, Torrents D, Weng Z, Armstrong SA, Kentsis A. Henssen AG, et al. Nat Genet. 2017 Jul;49(7):1005-1014. doi: 10.1038/ng.3866. Epub 2017 May 15. Nat Genet. 2017. PMID: 28504702 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Author Correction: PGBD5 promotes site-specific oncogenic mutations in human tumors

Affiliations

Author Correction: PGBD5 promotes site-specific oncogenic mutations in human tumors

Authors

Affiliations

Abstract

Erratum for

Publication types

LinkOut - more resources

Full Text Sources